Table 2.

Clinical applications of transient elastography

Controlled attenuation parameter	- Diagnosis of fatty liver
	- Screening for fatty liver in the general population of high-risk individuals (e.g., type 2 diabetes and obesity)
	- Monitor changes in liver fat (need more data)
Liver stiffness measurement	- Estimate severity of liver fibrosis in NAFLD patients
	- Selecting patients for clinical trials or pharmacological treatment
	- Screen for liver fibrosis in the general population of high-risk individuals (e.g., type 2 diabetes and obesity)
	- Predict varices needing treatment, hepatocellular carcinoma and liver-related death
	- Monitor changes in liver fibrosis (need more data)

NAFLD, nonalcoholic fatty liver disease.